As the biopharma landscape evolves, so does the need for robust patent portfolio strategies that not only protect inventions but also add significant value to therapeutic innovations.

This session will help you implement effective strategies for monetizing IP assets and maximizing value in an increasingly competitive marketplace. Topics of discussion will include:

• Tailoring your IP strategy to cover key aspects of novel therapies and regenerative medicines, from composition to method of use
• Balancing breadth and enforceability in patent claims for novel therapeutics
• Identifying and leveraging opportunities for licensing, cross-licensing, or selling IP rights
• Structuring IP-driven deals to attract investors and partners
• Conducting thorough IP audits to eliminate redundancies and focus on high-value assets
• Aligning IP strategy with business goals in partnerships and M&A activities